Meet us in Boston, USA to explore Optimer? as antibody alternatives

Our Director of Business Development, Derek Smith , will be in Boston from March 4 to March 7, 2024. Meet with him to learn how Optimer? binders are offering new solutions as targeted therapies, tools for drug discovery and in improving assay selectivity and sensitivity.

Working with 75% of the top twenty pharma, Aptamer Group is transforming affinity ligands with custom developed target and application-tuned antibody alternatives. Optimer binders are optimized for high selectivity and affinity to enable new solutions across research, diagnostics, therapeutics, and bioprocessing applications.

If you are in Boston, let’s meet and explore how we can help you to overcome your current challenges and make your science unlimited with Optimer.

Comment below to schedule a meeting or email us at [email protected].

Best wishes

Aptamer Group Team